Steqeyma 130 mg concentrate for solution for infusion

Company:
Celltrion Healthcare Ireland Ltd.
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Ustekinumab
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/24/1844/003

130 mg/26 mL

L04AC05

Concentrate for solution for infusion